These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Circumferential spontaneous coronary artery dissection in an elderly man: a case report. Koga T; Sakamoto A; Nakamura Y; Kawazoe N; Sadoshima S; Onoyama K; Fujishima M Angiology; 1998 Jan; 49(1):83-6. PubMed ID: 9456170 [TBL] [Abstract][Full Text] [Related]
49. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Dalen JE; Alpert JS; Hirsh J Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222 [No Abstract] [Full Text] [Related]
51. New strategy of thrombolysis. Conjunctive effect of plasminogen activators with different pharmacokinetic profile. Maksimenko AV Ann N Y Acad Sci; 1998 Dec; 864():96-105. PubMed ID: 9928084 [TBL] [Abstract][Full Text] [Related]
52. Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life. Weinheimer CJ; James HL; Kalyan NK; Wilhelm J; Lee SG; Hung PP; Sobel BE; Bergmann SR Circulation; 1991 Apr; 83(4):1429-36. PubMed ID: 1901531 [TBL] [Abstract][Full Text] [Related]
53. Aneurysm of the left main coronary artery without obstructive disease: report of a case presenting with severe unstable angina and treated with systemic thrombolysis. La Vecchia L; Bedogni F; Ometto R; Mosele GM; Vincenzi M Cathet Cardiovasc Diagn; 1993 Dec; 30(4):306-9. PubMed ID: 8287456 [TBL] [Abstract][Full Text] [Related]
55. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction. Collen D; Van de Werf F Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077 [TBL] [Abstract][Full Text] [Related]
56. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177 [TBL] [Abstract][Full Text] [Related]
57. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. Clare AC; Kraje BJ J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162 [TBL] [Abstract][Full Text] [Related]
58. Two-vessel spontaneous coronary artery dissection as a rare cause of acute coronary syndrome. Plonczak A; Luther V; Kaprielian R Heart; 2013 Jul; 99(13):970. PubMed ID: 23376903 [No Abstract] [Full Text] [Related]
59. Preinfarction angina. Kloner RA; Gibson M; Cannon C; Braunwald E N Engl J Med; 1996 Jul; 335(1):59-60; author reply 60-1. PubMed ID: 8637553 [No Abstract] [Full Text] [Related]
60. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction. Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]